BPC-157 / TB-500

BPC-157 / TB-500 Blend - Paired Tissue Repair Peptides

This blend combines two of the most widely studied repair-focused research peptides in a single vial: BPC-157 (Body Protection Compound-157, a 15-amino-acid fragment originally isolated from human gastric juice) and TB-500 (the synthetic N-terminal fragment of Thymosin Beta-4). Researchers pair them because each peptide acts through a different mechanism: BPC-157 is most closely associated with angiogenic (blood-vessel-forming) pathways and gut signaling, while TB-500 is associated with actin regulation and cell migration. Combining them lets researchers study the two mechanisms on the same timeline without running parallel experiments.

Why Researchers Pair Them

BPC-157 and TB-500 target different parts of the tissue-repair cascade. BPC-157 is most often cited in literature on vascular formation (angiogenesis) and gastrointestinal signaling, and it has an unusually stable oral profile for a peptide. TB-500 is studied for its effect on cellular migration, actin polymerization, and recruitment of repair cells to injured tissue. The pair is sometimes described as a “scaffold plus traffic” combination: one builds the structural substrate, the other moves repair cells into position.

Applicazioni di ricerca

The blend is used in studies examining:

• Soft-tissue repair models - tendon, ligament, and muscle
• Gastrointestinal protection and mucosal repair models
• Vascular formation and wound-healing substrates
• Cross-mechanism study designs comparing single-peptide vs. stacked protocols
• Recovery modeling after controlled tissue injury

Specifiche tecniche

Storage & Handling

Unopened vials are kept at 2-8°C under standard cold-chain conditions and remain stable for 12+ months. Reconstitution parameters, solvent compatibility, and post-reconstitution stability for BPC-157 / TB-500 are documented in the published peer-reviewed literature and standard peptide-chemistry references.

Reference Literature

Published clinical and preclinical BPC-157 / TB-500 literature is available through PubMed, Google Scholar, and other peer-reviewed databases. WWP does not provide protocol design, dosing guidance, or administration parameters. Those decisions rest with the researcher and any applicable institutional review board.

Common Questions About the Blend

What are BPC-157 and TB-500 used for in research?

Both peptides are studied in tissue-repair models. BPC-157 is most often cited in gastrointestinal and vascular-repair literature; TB-500 is most often cited in muscle-injury and cardiovascular-repair literature. Researchers pair them to study the two mechanisms simultaneously.

Why combine BPC-157 with TB-500 instead of using either alone?

The peptides act through different pathways - angiogenesis (BPC-157) and actin-mediated cell migration (TB-500) - which lets researchers characterize the combined effect within a single study timeline. Published protocols typically report a roughly 1:1 ratio.

How does the blend differ from GLOW?

GLOW is a three-peptide blend (BPC-157 + TB-4 + GHK-Cu) that adds a copper peptide to the BPC-157/TB-500 base. This 2-peptide blend is simpler and lets researchers study the BPC/TB-500 pair without the added GHK-Cu variable.

Is the BPC-157 / TB-500 blend FDA approved?

No. Neither BPC-157 nor TB-500 is FDA approved for any human use. TB-500 (Thymosin Beta-4) is listed on the WADA Prohibited List for competitive athletes. Every vial WWP ships is labeled and sold strictly for laboratory and research use only.

How is the blend stored?

Le fiale non aperte vanno conservate a una temperatura compresa tra 2 e 8 °C e mantengono la loro stabilità per oltre 12 mesi. Una volta ricostituita con acqua batteriostatica, la soluzione va conservata a una temperatura compresa tra 2 e 8 °C e utilizzata entro 28-30 giorni.

Garanzia di purezza

Ogni lotto ha una purezza pari o superiore al 99%. Inviateci un certificato di analisi (COA) redatto da un ente indipendente e vi accrediteremo un buono acquisto indipendentemente dai risultati riportati.